Response of circulating metabolites to an oral glucose challenge and risk of cardiovascular disease and mortality in the community

被引：0
|
作者：
Daniel Gonzalez Izundegui
Patricia E. Miller
Ravi V. Shah
Clary B. Clish
Maura E. Walker
Gary F. Mitchell
Robert E. Gerszten
Martin G. Larson
Ramachandran S. Vasan
Matthew Nayor
机构：
[1] Boston University School of Medicine,Department of Medicine
[2] Boston University School of Public Health,Department of Biostatistics
[3] Vanderbilt University Medical Center,Vanderbilt Translational and Clinical Research Center, Cardiology Division
[4] Broad Institute of MIT and Harvard,Section of Preventive Medicine and Epidemiology, Department of Medicine
[5] Boston University School of Medicine,Department of Health Sciences, Program in Nutrition, Sargent College of Health and Rehabilitation Sciences
[6] Boston University,Boston University’s and National Heart
[7] Lung,Division of Cardiovascular Medicine
[8] and Blood Institute’s Framingham Heart Study,Section of Cardiovascular Medicine, Department of Medicine
[9] Cardiovascular Engineering,Department of Epidemiology, Boston University Schools of Medicine and Public Health, Center for Computing and Data Sciences
[10] Inc,undefined
[11] Beth Israel Deaconess Medical Center,undefined
[12] Boston University School of Medicine,undefined
[13] Boston University,undefined
来源：
Cardiovascular Diabetology | / 21卷
关键词：
Metabolism; Metabolomics; Prevention; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Glucagon response to oral glucose challenge in type 1 diabetes
    Jecht, M.
    DIABETOLOGE, 2014, 10 (04): : 317 - 318
  • [32] Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community
    Hagstrom, Emil
    Hellman, Per
    Larsson, Tobias E.
    Ingelsson, Erik
    Berglund, Lars
    Sundstrom, Johan
    Melhus, Hakan
    Held, Claes
    Lind, Lars
    Michaelsson, Karl
    Arnlov, Johan
    CIRCULATION, 2009, 119 (21) : 2765 - U34
  • [33] VARIATIONS IN CARDIOVASCULAR-DISEASE MORTALITY BY TIME AND PLACE - THE CHALLENGE
    BEAGLEHOLE, R
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1990, 20 (05): : 636 - 638
  • [34] Glucose: a continuous risk factor for cardiovascular disease
    Gerstein, HC
    DIABETIC MEDICINE, 1997, 14 (08) : S25 - S31
  • [35] Vitamin D Metabolites and Risk of Cardiovascular Disease in CKD
    Hsu, Simon
    Bansal, Nisha
    Brown, Julia
    Denburg, Michelle
    Feldman, Harold I.
    Ginsberg, Charles
    Hoofnagle, Andrew N.
    Isakova, Tamara
    Kestenbaum, Bryan R.
    Lidgard, Benjamin
    Robinson-Cohen, Cassianne
    Zelnick, Leila R.
    de Boer, Ian H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 219 - 219
  • [36] Glucose Lowering, Hypoglycemia, and Cardiovascular Disease Risk
    Reboldi G.
    Gentile G.
    Angeli F.
    Mazzotta G.
    Martire P.
    Garofoli M.
    Verdecchia P.
    Current Cardiovascular Risk Reports, 2010, 4 (2) : 159 - 164
  • [37] Fasting blood glucose and risk of cardiovascular disease
    Balkau, B
    Jarrett, RJ
    Pyörälä, K
    Eschwège, E
    DIABETES CARE, 1999, 22 (08) : 1385 - 1386
  • [38] Oral anaerobe bacteria-a common risk for cardiovascular disease and mortality and some forms of cancer?
    Haheim, Anne Lise Lund
    FRONTIERS IN ORAL HEALTH, 2024, 5
  • [39] Fitness and Reclassification of Risk for Cardiovascular Disease Mortality
    Gupta, Sachin
    Rohatgi, Anand
    Ayers, Colby R.
    Willis, Banjamin
    Haskell, William
    Khera, Amit
    Drazner, Mark H.
    de Lemos, James A.
    Berry, Jarett D.
    CIRCULATION, 2010, 122 (21)
  • [40] Prolonged Sitting and the Risk of Cardiovascular Disease and Mortality
    Taylor W.C.
    Current Cardiovascular Risk Reports, 2011, 5 (4) : 350 - 357
12345